71287-119 : Yescarta 2000000 1/68ml Intravenous Suspension


NDC: 71287-119
Labeler: Kite Pharma, Inc.
Product Type: Cellular Therapy
Drug Name: Yescarta
Dosage Form: Intravenous Suspension
Application #: BLA125643
Rev. Date: 


NDC Package Codes:

  • 71287-119-02: 1 BAG IN 1 PACKAGE (71287‑119‑02) > 68 ML IN 1 BAG (71287‑119‑01)

Active Ingredients:

  • Axicabtagene Ciloleucel

Dosage Strength:

  • 2000000 1/68mL

Pharmaceutical Classes:

  • CD19 Receptor Interactions [MoA]
  • CD19-directed Chimeric Antigen Receptor [EPC]
  • CD19-specific Chimeric Antigen Receptor [CS]
  • Genetically-modified Autologous T Cells [EPC]
  • Increased T Lymphocyte Activation [PE]
  • T Lymphocytes
  • Cultured
  • Autologous
  • Genetically-modified [EXT]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71287-119 QR Code

< Prev: 71284-0001Next: 71287-219 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.